|
|
 |
Updated May 03, 2008
|
|
|
What's New
Hour Detroit Magazine Recognizes
Dr. Robert Robins as Top DocLinks:
Cervical Cancer Vaccine
Associated OB/GYN physicians offer "Gardasil," the vaccine for the prevention of cervical cancer, for the prevention of cervical, vulvar and vaginal pre-cancers caused by human papillomavirus (HPV), and for the prevention of genital warts.
The U.S. Food and Drug Administration (FDA) approved Gardasil on June 8, 2006.
“As the first vaccine designed to prevent cancer, Gardasil is a major medical breakthrough,” says Adam Ziff, D.O. “In line with our commitment to women’s health, we are looking forward to bringing this vaccine to the women in our community.”
According to the Centers for Disease Control, approximately 20 million people are currently infected with HPV. At least 50 percent of sexually active men and women acquire genital HPV infection at some point in their lives. By age 50, at least 80 percent of women will have acquired genital HPV infection. About 6.2 million Americans get a new genital HPV infection each year.
Approximately 10,000 women are diagnosed with cervical cancer each year, and an average of 10 women die each day from this cancer. HPV also causes approximately 40 to 50 percent of the more than 3,500 cases of vulvar and vaginal cancer that are diagnosed each year in the U.S.; about three women die each day from these two cancers. Certain types of HPV cause genital warts. Approximately 1 million cases of genital warts occur each year in the United States and an estimated 32 million cases occur worldwide. HPV-related diseases cost about $5 billion per year in the United States.
To schedule a private consultation with one of our physicians, please call (248) 338-0100 (Pontiac) or (248) 620-2800 (Clarkston). If you would like more information about Gardasil, please select from the following list:
Take a look at
Previous What's New Articles
|
|